Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Accelerate Diagnostics, Inc. of $150 million aggregate principal amount…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
